Eli Lilly now has the primary efficacy dataset required for an NDA filing, which remains expected before the end of 2026 pending TRIUMPH-2 data
That logic is appealing, and it is the reason L-carnitine has been studied in athletes, older adults, and people with overweight or obesity
I think the policy challenge isnt whether to use GLP-1s, but how to do so in a more equitable and sustainable way. Jaime Almandoz GLP-1s Are Expensive, But Changes Are Coming It is often reported that GLP-1 drugs can cost more than $1,000 a month
1 2 3 4 5 DORIS , consult le 10 juin 2026
Insurance plans typically only cover medication when it is taken as described in its FDA-approved form
Glow Blend (GHK-Cu, BPC-157, TB-500) typically comes in a 35 mg vial